Arkema SA (OTCMKTS:ARKAY) Short Interest Down 75.8% in July

Arkema SA (OTCMKTS:ARKAY) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 418 shares, a decrease of 75.8% from the July 15th total of 1,729 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,816 shares, the days-to-cover ratio is currently 0.1 days.

Arkema Trading Down 0.0%

Shares of ARKAY opened at $71.81 on Thursday. The stock has a fifty day moving average of $65.98 and a two-hundred day moving average of $67.85. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.64 and a current ratio of 2.25. The company has a market capitalization of $5.46 billion, a PE ratio of 247.62 and a beta of 0.85. Arkema has a fifty-two week low of $56.28 and a fifty-two week high of $79.36.

Arkema (OTCMKTS:ARKAY) last posted its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.12. Arkema had a return on equity of 4.27% and a net margin of 0.67%.The business had revenue of $2.79 billion for the quarter, compared to analysts’ expectations of $2.86 billion. As a group, analysts forecast that Arkema will post 3.67 EPS for the current year.

Analysts Set New Price Targets

ARKAY has been the subject of a number of analyst reports. Berenberg Bank cut Arkema from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Sanford C. Bernstein upgraded Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Zacks Research raised shares of Arkema from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. The Goldman Sachs Group downgraded shares of Arkema from a “buy” rating to a “neutral” rating in a research note on Monday, June 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Arkema in a research note on Tuesday, June 23rd. One analyst has rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Arkema has a consensus rating of “Reduce”.

Arkema Company Profile

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.